GENFIT Overview
Company Headquarters: Loos, France
Founded: 1999
Workforce: ~170
Company Working: GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases. The company is currently developing a non-invasive and easy-to-access blood-based IVD test to identify patients with NASH. Also, the company’s pipeline drug, Elafibranor is assessed under phase III clinical trial as a potential treatment for NASH. The company operates in only one segment, the research & development of innovative medicines. The company has its operational facilities in Lille and Paris, France, and Cambridge, Massachusetts, US.
Strategy
GENFIT aims to develop innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases. The company also focuses on value-based healthcare principles to drive global growth. GENFIT focuses on becoming a leading company in the field of liver disease diagnosis by entering into various strategic mergers and ventures.



